Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001608936-26-000002

Options or other derivatives

  • PRESIDENT AND CEO acquired 787,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Chacko Jacob PRESIDENT AND CEO 2026-01-02 Grant or award · Stock Option (right to buy) +675,000 675,000 D
Chacko Jacob PRESIDENT AND CEO 2026-01-02 Grant or award · Restricted Stock Unit +112,500 112,500 D
Loading xslF345X05/form4-01062026_090105.xml…